Clinical Trial Update: Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a 50 µg booster dose of the recombinant ricin toxin vaccine RVEc™ in previously vaccinated healthy adults; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ricin Poisoning

Drugs mentioned

• RVEc (recombinant ricin toxin A-chain vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Ricin Poisoning | Phase 1 | Status: COMPLETED | Results posted: 2016-11-21